Cargando…
Prostate Tumor Overexpressed-1 (PTOV1) promotes docetaxel-resistance and survival of castration resistant prostate cancer cells
Metastatic prostate cancer is presently incurable. The oncogenic protein PTOV1, first described in prostate cancer, was reported as overexpressed and significantly correlated with poor survival in numerous tumors. Here, we investigated the role of PTOV1 in prostate cancer survival to docetaxel and s...
Autores principales: | Cánovas, Verónica, Puñal, Yolanda, Maggio, Valentina, Redondo, Enric, Marín, Mercedes, Mellado, Begoña, Olivan, Mireia, Lleonart, Matilde, Planas, Jacques, Morote, Juan, Paciucci, Rosanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601723/ https://www.ncbi.nlm.nih.gov/pubmed/28938627 http://dx.doi.org/10.18632/oncotarget.19467 |
Ejemplares similares
-
The role of prostate tumor overexpressed 1 in cancer progression
por: Cánovas, Verónica, et al.
Publicado: (2016) -
Definition of Castrate Resistant Prostate Cancer: New Insights
por: Morote, Juan, et al.
Publicado: (2022) -
Prostate tumor OVerexpressed-1 (PTOV1) down-regulates HES1 and HEY1 notch targets genes and promotes prostate cancer progression
por: Alaña, Lide, et al.
Publicado: (2014) -
Cytokine profiling of docetaxel-resistant castration-resistant prostate cancer
por: Mahon, K L, et al.
Publicado: (2015) -
Plasma Androgen Receptor and Docetaxel for Metastatic Castration-resistant Prostate Cancer
por: Conteduca, Vincenza, et al.
Publicado: (2019)